Identification of 2,4-dihydroxy-5-pyrimidinyl imidothiocarbomate as a novel inhibitor to Y box binding protein-1 (YB-1) and its therapeutic actions against breast cancer-Reference-Cited by-同舟云学术

Identification of 2,4-dihydroxy-5-pyrimidinyl imidothiocarbomate as a novel inhibitor to Y box binding protein-1 (YB-1) and its therapeutic actions against breast cancer

Published:2018-04 Issue: Volume:116 Page:2-14
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Gunasekaran Vinoth Prasanna,Nishi Kumari,Sivakumar Dakshinamurthy,Sivaraman Thirunavukkarasu,Mathan Ganeshan^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference63 articles.

1. Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics;Akinleye;J. Hematol. Oncol.,2013

2. YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification;Bergmann;Cancer Res.,2005

3. PI3K therapy reprograms mitochondrial trafficking to fuel tumor cell invasion;Caino;Proc. Natl. Acad. Sci.,2015

4. Interplay between YB-1 and IL-6 promotes the metastatic phenotype in breast cancer cells;Castellana;Oncotarget,2015

5. Molecular insights into the anti-cancer properties of traditional Tibetan medicine YukyungKarne;Choedon;BMC Complement. Altern. Med.,2014

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNA-binding proteins in breast cancer: Biological implications and therapeutic opportunities;Critical Reviews in Oncology/Hematology;2024-03

2. Y-Box Binding Protein 1: Unraveling the Multifaceted Role in Cancer Development and Therapeutic Potential;International Journal of Molecular Sciences;2024-01-05

3. Iodine-catalyzed regioselective direct sulfenylation of uracil with sulfonyl hydrazide as sulfur source under solvent free conditions;RSC Advances;2024

4. YB-1 activating cascades as potential targets in KRAS-mutated tumors;Strahlentherapie und Onkologie;2023-06-02

5. Involvement of a AS3MT / c‐Fos /p53 signaling axis in arsenic‐induced tumor in human lung cells;Environmental Toxicology;2022-11-18